(Stroke. 1999;30:851-854.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Department of Medicine, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond, Va.
Correspondence to Hermes A. Kontos, MD, PhD, Medical College of Virginia Campus, Virginia Commonwealth University, PO Box 980549, Richmond, VA 23298-0549. E-mail hakontos{at}vcu.edu
| Abstract |
|---|
|
|
|---|
MethodsWe investigated the effect of 3 agents that in earlier studies were found to inhibit KATP channelsNG-nitro-L-arginine, hydroxylysine, and glyburideon the cerebral arteriolar constriction caused by graded hypocapnia induced by hyperventilation in anesthetized cats equipped with cranial windows.
ResultsHypocapnic alkalosis caused dose-dependent vasoconstriction that was inhibited completely by each of the 3 inhibitors of KATP channels. The blockade induced by these agents was eliminated in the presence of topical L-lysine (5 µmol/L).
ConclusionsThe findings show that agents which inhibit ATP-sensitive potassium channels in cerebral arterioles inhibit the vasoconstriction from hypocapnic alkalosis. These and earlier results showing that inhibition of KATP channels inhibited dilation from hypercapnic acidosis demonstrate that the response to CO2 in cerebral arterioles is mediated by the opening and closing of KATP channels.
Key Words: carbon dioxide glyburide hydroxylysine microcirculation nitroarginine vasoconstriction cats
| Introduction |
|---|
|
|
|---|
Recent findings,2 however, have shown that the arginine analogs also block ATP-sensitive potassium (KATP) channels and that the vasodilation from hypercapnic acidosis is also blocked by known inhibitors of KATP channels, such as glyburide, which do not affect nitric oxide synthesis. It is therefore likely that the vasodilation from hypercapnic acidosis is due to opening of KATP channels.
Although many studies tested the effect of agents that block KATP channels or nitric oxide synthase on the response to hypercapnic acidosis, we can find no studies in which the effect of these agents on the response to hypocapnic alkalosis was tested. Because the response to CO2 is a continuum, with hypercapnic acidosis causing vasodilation and hypocapnic alkalosis causing vasoconstriction, it would be expected that the response to hypocapnic alkalosis would also be mediated by the same mechanism as that due to hypercapnic acidosis. In the present experiments we tested the effect of 3 agents that block KATP channels in cerebral arterioles on the vasoconstrictor response to hypocapnic alkalosis in anesthetized cats.
| Materials and Methods |
|---|
|
|
|---|
The cerebral microcirculation of the parietal cortex was visualized through an acutely implanted cranial window, as described in detail previously.3 The space under the cranial window was filled with artificial cerebrospinal fluid (CSF) identical in composition to that of cats. One port of the window was connected to a pressure transducer for continuous monitoring of intracranial pressure. The intracranial pressure was maintained at 5 mm Hg by connecting another outlet of the window to a coiled plastic tube whose free end was placed at the appropriate height to give the desired pressure. Two ports of the cranial window were used as inlet and outlet, allowing topical application of various solutions. Pial arteriolar diameter was measured with an image-splitting device attached to a microscope. In each animal, several arterioles were observed, covering a wide range of vessel caliber. The responses of small and large arterioles (smaller and larger than 100 µm in diameter, respectively) were analyzed separately to identify any size-dependent differences in responses.
Glyburide, hydroxylysine, L-NNA, and L-lysine were obtained from Sigma Chemical Co. All agents were dissolved in artificial CSF except for glyburide, which was dissolved in ethyl alcohol to produce a stock solution. Appropriate dilutions from the stock solution were then prepared in artificial CSF.
The experimental design was as follows: The response to 2 levels of hypocapnic alkalosis of cerebral arterioles was tested in a control experiment without pretreatment. Hypocapnic alkalosis was induced by increasing the volume and frequency of the respirator. Each level of hypocapnia was maintained for at least 10 minutes to obtain steady-state responses. Measurements were made at PaCO2 of 22 and 16 mm Hg. The experiment was repeated after topical treatment with 1 of 3 blockers of KATP channels. These agents were applied topically by filling the window with the appropriate solutions. We used hydroxylysine 1 mmol/L, L-NNA 250 µmol/L, or glyburide 1 µmol/L. Each blocker was used in 5 cats. The response to hypocapnic alkalosis was tested again 30 minutes after the application of the blocker. A third test of the responses to hypocapnic alkalosis was carried out in the presence of topical application of 5 µmol/L L-lysine. It was shown previously4 that L-lysine or L-arginine in micromolar concentrations reversed the blockade of KATP channels induced by glyburide, L-NNA, or hydroxylysine.
Statistical analysis of the results was done with ANOVA followed by t tests modified for multiple comparisons.
| Results |
|---|
|
|
|---|
|
|
|
| Discussion |
|---|
|
|
|---|
Electrophysiological and supporting pharmacological evidence showed the presence of KATP channels in smooth muscle from cerebral arteries of rabbits.7 In addition, based on the finding that glyburide caused substantial depolarization in cerebral arteries,8 it was suggested that ATP-sensitive potassium channels may be open under resting conditions in these vessels.8 We are not aware of any studies in which blockade of KATP channels by glyburide interfered with vasoconstrictor responses in vivo. However, it was shown that serotonin and histamine, in isolated smooth muscle cells from cerebral arteries, decreased glyburide-sensitive inward potassium currents, suggesting that these agents are capable of closing down KATP channels.7 Similar findings have been shown in response to a number of vasoconstrictor agents in bladder smooth muscle9 as well as in coronary10 11 12 and mesenteric vascular smooth muscle.13
Our studies are based exclusively on the use of pharmacological agents. The conclusion, therefore, that the vasoconstrictor response to hypocapnia is mediated by closing of KATP channels is dependent on the specificity of the agents we used to block these channels. In this respect, it is well established that glyburide is highly specific in blocking KATP channels in cerebral vessels. For example, several investigators14 15 16 found that the administration of glyburide did not affect responses due to agents which open calcium-activated potassium channels. Similarly, agents that are known to block calcium-activated potassium channels, such as iberiotoxin, charybdotoxin, and tetraethyl-ammonium chloride, did not affect responses due to synthetic KATP channel openers.14 15 17 18 19
The specificity of the responses is also demonstrated by the fact that the blockade induced by the 3 blocking agents we used was readily removed by a low concentration of L-lysine. Earlier studies4 showed that KATP channels in cerebral arterioles require binding of L-lysine or L-arginine to open in response to agonists, such as pinacidil. The 3 agents we used to block these channels, namely, glyburide, L-NNA, and hydroxylysine, evidently block these channels by displacing L-arginine or L-lysine from the channel.4 In the presence of micromolar concentrations of L-lysine or L-arginine in the fluid bathing the vessels, the blockade induced by these agents is removed.4
It is worthy of note that blockade of KATP channels in cerebral arteries did not change baseline diameter. Others20 have also found that blockade of KATP channels in cerebral vessels does not cause a change in baseline vascular caliber. Electrophysiological studies8 have shown that blockade of these channels causes a large depolarization of isolated cerebral arteries without a change in basal tone. The surprising absence of change in basal tone was ascribed to the fact that the depolarization may not have reached the threshold for activating vasoconstrictor mechanisms.8 In our in vivo experiments, another reasonable explanation for the absence of a change in baseline diameter is the fact that agents which are present in the vicinity of vessels under resting conditions may have competing influences on KATP channels, some of them acting on these channels to cause vasodilation and others to cause vasoconstriction. The blockade of the channels by elimination of opposing actions on these channels may result in no net change in baseline diameter.
The relaxation of isolated basilar arteries in response to acidosis was blocked by glyburide but unaffected by charybdotoxin.5 Also, the dilation of isolated coronary arteries due to acidosis was inhibited by glyburide but not iberiotoxin.6 In unpublished studies we found that charybdotoxin did not modify the cerebral arteriolar dilation due to hypercapnia in rats (authors' unpublished data, 1998). Thus, the available evidence does not support participation of calcium-activated potassium channels in the cerebral vascular response to CO2.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received August 7, 1998; revision received November 19, 1998; accepted January 4, 1999.
| References |
|---|
|
|
|---|
2.
Kontos HA, Wei EP. Arginine analogues inhibit
responses mediated by ATP-sensitive K+ channels.
Am J Physiol. 1996;271:H1498H1506.
3.
Levasseur JE, Wei EP, Raper AJ, Kontos HA, Patterson
JL Jr. Detailed description of a cranial window technique for acute and
chronic experiments. Stroke. 1975;6:308317.
4. Kontos HA, Wei EP. Cerebral arteriolar dilations by KATP channel activators need L-lysine or L-arginine. Am J Physiol. 1998;274:H974H981.
5.
Kinoshita H, Katusic ZS. Role of potassium channels in
relaxations of isolated canine basilar arteries to acidosis.
Stroke. 1997;28:433438.
6.
Ishizaka H, Kuo L. Acidosis-induced coronary
arteriolar dilation is mediated by ATP-sensitive potassium channels in
vascular smooth muscle. Circ Res. 1996;78:5057.
7.
Kleppish, T, Nelson, MT. ATP-sensitive
K+ currents in cerebral arterial
smooth muscle: pharmacological and hormonal modulation. Am J
Physiol. 1995;269:H1634H1640.
8.
Nagao, T, Ibayashi, S, Sadoshima, S, Fujii, K,
Fujii, K, Ohya, Y, Fujishima, M. Distribution and
physiological roles of ATP-sensitive
K+ channels in the vertebrobasilar system of the
rabbit. Circ Res. 1996;78:238243.
9.
Bonev, AD, Nelson, MT. Muscarinic inhibition of
ATP-sensitive K+ channels by protein kinase C in
urinary bladder smooth muscle. Am J Physiol. 1993;265:C1723C1728.
10.
Miyoshi, Y, Nakaya, Y, Wakatsuki, T, Nakaya, S, Fujino,
K, Saito, K, Inoue, I. Endothelin blocks ATP-sensitive
K+ channels and depolarizes smooth muscle cells
of porcine coronary artery. Circ Res. 1992;70:612616.
11. Miyoshi, Y, Nakaya, Y. Angiotensin II blocks ATP-sensitive K+ channels in porcine coronary artery smooth muscle cells. Biochem Biophys Res Commun. 1991;181:700706.[Medline] [Order article via Infotrieve]
12.
Wakatsuki, T, Nakaya, Y, Inoue, I. Vasopressin
modulates K+ channel activities of cultured
smooth muscle cells from porcine coronary artery. Am
J Physiol. 1992;263:H491H496.
13. Bonev, AD, Nelson, MT. Neuropeptide Y, phenylepinephrine serotonin, and histamine inhibit ATP-sensitive K+ channel currents by protein kinase C in smooth muscle cells from rabbit mesenteric artery. Biophys J. 1995;68:A46. Abstract.
14. Armstead, WM. Role of impaired cAMP and calcium-sensitive K+ channel function in altered cerebral hemodynamics following brain injury. Brain Res. 1997;768:177184.[Medline] [Order article via Infotrieve]
15. Wang, Q, Bryan, RM Jr, Pelligrino, DA. Calcium-dependent and ATP-sensitive potassium channels and the "permissive" function of cyclic GMP in hypercapnia-induced pial arteriolar relaxation. Brain Res. 1998;793:187196.[Medline] [Order article via Infotrieve]
16.
Wei, EP, Kontos, HA, Beckman, JS. Mechanisms of
cerebral vasodilation by superoxide, hydrogen peroxide, and
peroxynitrite. Am J Physiol. 1996;271:H1262H1266.
17.
Taguchi, H, Heistad, DD, Kitazono, T, Faraci, FM.
Dilatation of cerebral arterioles in response to activation of
adenylate cyclase is dependent on activation of
Ca2+-dependent K+ channels.
Circ Res. 1995;76:10571062.
18.
Mayhan, WG, Faraci, FM. Responses of cerebral
arterioles in diabetic rats to activation of ATP-sensitive potassium
channels. Am J Physiol. 1993;265:H152H157.
19.
Paternò, R, Faraci, FM, Heistad DD. Role of
Ca2+-dependent K+ channels
in cerebral vasodilation induced by increases in cyclic GMP and cyclic
AMP in the rat. Stroke. 1996;27:16031608.
20. Faraci FM, Breese KR, Heistad DD. Cerebral vasodilation during hypercapnia. Role of glibenclamide-sensitive potassium channels and nitric oxide. Stroke. 1994;25:16791683.[Abstract]
Department of Internal Medicine, Cardiovascular Center, University of Iowa College of Medicine, Iowa City, Iowa
| Introduction |
|---|
|
|
|---|
Some studies have suggested that activation of one type of potassium channel, the ATP-sensitive potassium channel KATP, may contribute to dilation of cerebral blood vessels during hypercapnia.13 The present study presents new data which suggest that these potassium channels are involved in the vascular response to hypocapnia. This conclusion is based in part on the finding that glibenclamide, which inhibits KATP, blocked constriction of cerebral arteries and arterioles in responses to hypocapnia. In addition, the response to hypocapnia was attenuated by NG-nitro-L-arginine and hydroxylysine. These latter substances are not traditionally used as inhibitors of KATP, but they inhibit dilation of cerebral vessels in response to activators of these potassium channels in the feline model used in these experiments. The finding that three structurally unrelated compounds produced similar results provides strong evidence that inhibition of responses to hypocapnia did not reflect some nonspecific effect.
Although many studies have examined effects of glibenclamide on vasodilator stimuli,4,5 almost none have examined effects of this drug on constrictor responses in the cerebral circulation. Implicit in the interpretation of the present findings, that glibenclamide (and other inhibitors) attenuate vasoconstriction during hypocapnia, is the assumption that KATP are active (open) under basal conditions. This assumption is not consistent with the finding of many studies (including the data in the authors' study) that glibenclamide does not alter resting tone of cerebral blood vessels, which suggests that KATP are not open under basal conditions.4,5 As the authors note, however, other mechanisms also influence vascular tone, and perhaps these other mechanisms maintain vessel diameter constant during application of glibenclamide in vivo.
Measurement in vivo of membrane potential, a variable that is very sensitive to activity of potassium channels, during application of glibenclamide would help greatly to determine whether KATP are open under basal conditions and thus have the potential to close and produce vasoconstriction. Unfortunately, in vivo measurements of membrane potential in cerebral blood vessels have not been reported. Previous studies in vitro have reported that glibenclamide does not alter resting membrane potential5 or it depolarizes cerebral vascular muscle.6 The latter effect would be consistent with inhibition of activity of KATP. The present study is the first to examine the effects of glibenclamide on responses to a vasoconstrictor stimulus in brain in vivo. Additional studies will be needed to determine whether this effect of glibenclamide is observed in other models and during other vasoconstrictor stimuli.
Received August 7, 1998; revision received November 19, 1998; accepted January 4, 1999.
| References |
|---|
|
|
|---|
2. Kinoshita H, Katusic ZS. Role of potassium channels in relaxations of isolated canine basilar ateries to acidosis. Stroke.. 1997;28:433438.
3. Faraci FM, Breese KR, Heistad DD. Cerebral vasodilation during hypercapnia: role of glibenclamide-sensitive potassium channels and nitric oxide. Stroke.. 1994;25:16791683.
4. Faraci FM, Sobey CG. Role of potassium channels in regulation of cerebral vascular tone. J Cereb Blood Flow Metab.. 1998;18:10471063.[Medline] [Order article via Infotrieve]
5.
Quayle JM, Nelson MT, Standen NB. ATP-sensitive and
inwardly rectifying potassium channels in smooth muscle. Physiol
Rev.. 1997;77:11651232.
6. Nagao T, Ibayashi S, Sadoshima S, Fujii K, Fujii K, Ohya Y, Fujishima M. Distribution and physiological roles of ATP-sensitive K+ channels in the vertebrobasilar system of the rabbit. Circ Res.. 1996;78:238243.
This article has been cited by other articles:
![]() |
E. A. Mokelke, N. J. Dietz, D. M. Eckman, M. T. Nelson, and M. Sturek Diabetic dyslipidemia and exercise affect coronary tone and differential regulation of conduit and microvessel K+ current Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1233 - H1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Pennings, G. J. Bouma, and C. Ince Direct Observation of the Human Cerebral Microcirculation During Aneurysm Surgery Reveals Increased Arteriolar Contractility Stroke, June 1, 2004; 35(6): 1284 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, J. Wu, L. Li, F. Chen, R. Wang, and C. Jiang Hypercapnic Acidosis Activates KATP Channels in Vascular Smooth Muscles Circ. Res., June 13, 2003; 92(11): 1225 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. I. Rosenblum ATP-Sensitive Potassium Channels in the Cerebral Circulation Stroke, June 1, 2003; 34(6): 1547 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, N. Cui, Z. Yang, J. Wu, L. R. Giwa, L. Abdulkadir, P. Sharma, and C. Jiang Direct Activation of Cloned KATP Channels by Intracellular Acidosis J. Biol. Chem., April 13, 2001; 276(16): 12898 - 12902. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |